{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:26:35Z","timestamp":1773109595643,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-66437-8","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:03:14Z","timestamp":1722855794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the globoid cell leukodystrophy protein network and therapeutic interventions"],"prefix":"10.1038","volume":"14","author":[{"given":"Pukar","family":"Khanal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal S.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit Kumar","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwambhar V.","family":"Bhandare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"key":"66437_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135841","volume":"752","author":"AM Bradbury","year":"2021","unstructured":"Bradbury, A. M., Bongarzone, E. R. & Sands, M. S. Krabbe disease: New hope for an old disease. Neurosci. Lett. 752, 135841. https:\/\/doi.org\/10.1016\/j.neulet.2021.135841 (2021).","journal-title":"Neurosci. Lett."},{"issue":"8","key":"66437_CR2","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/hmg\/ddac299","volume":"32","author":"MB Cach\u00f3n-Gonz\u00e1lez","year":"2023","unstructured":"Cach\u00f3n-Gonz\u00e1lez, M. B., Zhao, C., Franklin, R. J. & Cox, T. M. Upregulation of non-canonical and canonical inflammasome genes associates with pathological features in Krabbe disease and related disorders. Hum. Mol. Genet. 32(8), 1361\u20131379. https:\/\/doi.org\/10.1093\/hmg\/ddac299 (2023).","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"66437_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2020.05.025","volume":"107","author":"P Kratimenos","year":"2020","unstructured":"Kratimenos, P. & Gallo, V. Unexpected synergy: Macrophages and schwann cells modulate pathology in a newborn disease through a shared substrate. Neuron 107(1), 1\u20133. https:\/\/doi.org\/10.1016\/j.neuron.2020.05.025 (2020).","journal-title":"Neuron"},{"issue":"16","key":"66437_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJM199804163381605","volume":"338","author":"W Krivit","year":"1998","unstructured":"Krivit, W. et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N. Engl. J. Med. 338(16), 1119\u20131126. https:\/\/doi.org\/10.1056\/NEJM199804163381605 (1998).","journal-title":"N. Engl. J. Med."},{"key":"66437_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2021.106863","volume":"35","author":"A Noori","year":"2021","unstructured":"Noori, A., Mezlini, A. M., Hyman, B. T., Serrano-Pozo, A. & Das, S. Differential gene expression data from the human central nervous system across Alzheimer\u2019s disease, Lewy body diseases, and the amyotrophic lateral sclerosis and frontotemporal dementia spectrum. Data Brief 35, 106863. https:\/\/doi.org\/10.1016\/j.dib.2021.106863 (2021).","journal-title":"Data Brief"},{"issue":"2\u20133","key":"66437_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0165-0173(01)00103-5","volume":"36","author":"SE Antonarakis","year":"2001","unstructured":"Antonarakis, S. E., Lyle, R., Chrast, R. & Scott, H. S. Differential gene expression studies to explore the molecular pathophysiology of Down syndrome. Brain Res. Brain Res. Rev. 36(2\u20133), 265\u2013274. https:\/\/doi.org\/10.1016\/s0165-0173(01)00103-5 (2001).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"66437_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107090","volume":"162","author":"RK Chaudhary","year":"2023","unstructured":"Chaudhary, R. K. et al. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach. Comput. Biol. Med. 162, 107090. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107090 (2023).","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"66437_CR8","doi-asserted-by":"publisher","first-page":"19072","DOI":"10.1038\/s41598-023-46455-8","volume":"13","author":"FF Ahmed","year":"2023","unstructured":"Ahmed, F. F. et al. Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches. Sci. Rep. 13(1), 19072. https:\/\/doi.org\/10.1038\/s41598-023-46455-8 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"66437_CR9","first-page":"17","volume":"7","author":"N Safari-Alighiarloo","year":"2014","unstructured":"Safari-Alighiarloo, N., Taghizadeh, M., Rezaei-Tavirani, M., Goliaei, B. & Peyvandi, A. A. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterol. Hepatol. Bed Bench 7(1), 17\u201331 (2014).","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"issue":"18","key":"66437_CR10","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","volume":"20","author":"L Pinzi","year":"2019","unstructured":"Pinzi, L. & Rastelli, G. Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci. 20(18), 4331. https:\/\/doi.org\/10.3390\/ijms20184331 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"66437_CR11","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","volume":"59","author":"M De Vivo","year":"2016","unstructured":"De Vivo, M., Masetti, M., Bottegoni, G. & Cavalli, A. Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 59(9), 4035\u20134061. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01684 (2016).","journal-title":"J. Med. Chem."},{"issue":"16","key":"66437_CR12","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1021\/jm5004733","volume":"57","author":"N Ye","year":"2014","unstructured":"Ye, N., Ding, Y., Wild, C., Shen, Q. & Zhou, J. Small molecule inhibitors targeting activator protein 1 (AP-1). J. Med. Chem. 57(16), 6930\u20136948. https:\/\/doi.org\/10.1021\/jm5004733 (2014).","journal-title":"J. Med. Chem."},{"issue":"1","key":"66437_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","volume":"18","author":"R Wisdom","year":"1999","unstructured":"Wisdom, R., Johnson, R. S. & Moore, C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18(1), 188\u2013197. https:\/\/doi.org\/10.1093\/emboj\/18.1.188 (1999).","journal-title":"EMBO J."},{"issue":"4","key":"66437_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.200803013","volume":"181","author":"DB Parkinson","year":"2008","unstructured":"Parkinson, D. B. et al. c-Jun is a negative regulator of myelination. J. Cell Biol. 181(4), 625\u2013637. https:\/\/doi.org\/10.1083\/jcb.200803013 (2008).","journal-title":"J. Cell Biol."},{"issue":"1","key":"66437_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12864-023-09285-6","volume":"24","author":"Y Lv","year":"2023","unstructured":"Lv, Y. et al. Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling. BMC Genom. 24(1), 210. https:\/\/doi.org\/10.1186\/s12864-023-09285-6 (2023).","journal-title":"BMC Genom."},{"issue":"4","key":"66437_CR16","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3390\/app12042205","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X., Madhukar Kudke, A., Joseph Nepveux, V. F. & Xu, Y. Network-based pharmacology study reveals protein targets for medical benefits and harms of cannabinoids in humans. Appl. Sci. 12(4), 2205 (2022).","journal-title":"Appl. Sci."},{"issue":"D1","key":"66437_CR17","doi-asserted-by":"publisher","first-page":"D1288","DOI":"10.1093\/nar\/gkac813","volume":"51","author":"F Li","year":"2023","unstructured":"Li, F. et al. DrugMAP: Molecular atlas and pharma-information of all drugs. Nucleic Acids Res. 51(D1), D1288\u2013D1299. https:\/\/doi.org\/10.1093\/nar\/gkac813 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"66437_CR18","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A","year":"2014","unstructured":"Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A. g_mmpbsa: A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 54(7), 1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"66437_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2023.107957","volume":"107","author":"P Khanal","year":"2023","unstructured":"Khanal, P. et al. The marijuana-schizophrenia multifaceted nexus: Connections and conundrums towards neurophysiology. Comput. Biol. Chem. 107, 107957. https:\/\/doi.org\/10.1016\/j.compbiolchem.2023.107957 (2023).","journal-title":"Comput. Biol. Chem."},{"issue":"4","key":"66437_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/07391102.2017.1310670","volume":"36","author":"VV Bhandare","year":"2018","unstructured":"Bhandare, V. V. & Ramaswamy, A. The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: A computational study. J. Biomol. Struct. Dyn. 36(4), 1075\u20131093. https:\/\/doi.org\/10.1080\/07391102.2017.1310670 (2018).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"66437_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/07391102.1996.10508874","volume":"13","author":"A Amadei","year":"1996","unstructured":"Amadei, A., Linssen, A. B., de Groot, B. L., van Aalten, D. M. & Berendsen, H. J. An efficient method for sampling the essential subspace of proteins. J. Biomol. Struct. Dyn. 13(4), 615\u2013625. https:\/\/doi.org\/10.1080\/07391102.1996.10508874 (1996).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"66437_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.785964","volume":"12","author":"P Khanal","year":"2021","unstructured":"Khanal, P. et al. Integration of system biology tools to investigate Huperzine A as an anti-alzheimer agent. Front. Pharmacol. 12, 785964. https:\/\/doi.org\/10.3389\/fphar.2021.785964 (2021).","journal-title":"Front. Pharmacol."},{"issue":"13","key":"66437_CR23","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1016\/j.celrep.2019.11.100","volume":"29","author":"A Bonafina","year":"2019","unstructured":"Bonafina, A. et al. GDNF and GFR\u03b11 are required for proper integration of adult-born hippocampal neurons. Cell Rep. 29(13), 4308-4319.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.100 (2019).","journal-title":"Cell Rep."},{"issue":"2","key":"66437_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","volume":"138","author":"SJ Allen","year":"2013","unstructured":"Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U. & Patel, N. K. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol. Ther. 138(2), 155\u2013175. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.004 (2013).","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"66437_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/neurosci3040050","volume":"3","author":"SY Lara Aparicio","year":"2022","unstructured":"Lara Aparicio, S. Y. et al. Current opinion on the use of c-Fos in neuroscience. NeuroSci. 3(4), 687\u2013702 (2022).","journal-title":"NeuroSci."},{"issue":"17","key":"66437_CR26","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1523\/JNEUROSCI.18-17-06952.1998","volume":"18","author":"N Hiroi","year":"1998","unstructured":"Hiroi, N. et al. Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J. Neurosci. 18(17), 6952\u20136962. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-17-06952.1998 (1998).","journal-title":"J. Neurosci."},{"issue":"3","key":"66437_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1021\/acschemneuro.1c00723","volume":"13","author":"AJ Robison","year":"2022","unstructured":"Robison, A. J. & Nestler, E. J. \u0394FOSB: A potentially druggable master orchestrator of activity-dependent gene expression. ACS Chem. Neurosci. 13(3), 296\u2013307. https:\/\/doi.org\/10.1021\/acschemneuro.1c00723 (2022).","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"66437_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1471-4159.2008.05684.x","volume":"107","author":"G Raivich","year":"2008","unstructured":"Raivich, G. c-Jun expression, activation and function in neural cell death, inflammation and repair. J. Neurochem. 107(4), 898\u2013906. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05684.x (2008).","journal-title":"J. Neurochem."},{"issue":"33","key":"66437_CR29","doi-asserted-by":"publisher","first-page":"30010","DOI":"10.1074\/jbc.M202066200","volume":"277","author":"H Kaneto","year":"2002","unstructured":"Kaneto, H. et al. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem. 277(33), 30010\u201330018. https:\/\/doi.org\/10.1074\/jbc.M202066200 (2002).","journal-title":"J. Biol. Chem."},{"key":"66437_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1874312901206010220","volume":"6","author":"M Guma","year":"2012","unstructured":"Guma, M. & Firestein, G. S. c-Jun N-terminal kinase in inflammation and rheumatic diseases. Open Rheumatol. J. 6, 220\u2013231. https:\/\/doi.org\/10.2174\/1874312901206010220 (2012).","journal-title":"Open Rheumatol. J."},{"issue":"7","key":"66437_CR31","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/emboj\/16.7.1695","volume":"16","author":"E Bossy-Wetzel","year":"1997","unstructured":"Bossy-Wetzel, E., Bakiri, L. & Yaniv, M. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16(7), 1695\u20131709. https:\/\/doi.org\/10.1093\/emboj\/16.7.1695 (1997).","journal-title":"EMBO J."},{"key":"66437_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40560-015-0115-2","volume":"3","author":"M Ishida","year":"2015","unstructured":"Ishida, M. et al. T-5224, a selective inhibitor of c-Fos\/activator protein-1, improves survival by inhibiting serum high mobility group box-1 in lethal lipopolysaccharide-induced acute kidney injury model. J. Intensive Care 3, 49. https:\/\/doi.org\/10.1186\/s40560-015-0115-2 (2015).","journal-title":"J. Intensive Care"},{"key":"66437_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","volume":"60","author":"F Stanzione","year":"2021","unstructured":"Stanzione, F., Giangreco, I. & Cole, J. C. Use of molecular docking computational tools in drug discovery. Prog. Med. Chem. 60, 273\u2013343. https:\/\/doi.org\/10.1016\/bs.pmch.2021.01.004 (2021).","journal-title":"Prog. Med. Chem."},{"key":"66437_CR34","doi-asserted-by":"publisher","first-page":"34984","DOI":"10.1038\/srep34984","volume":"6","author":"I Aier","year":"2016","unstructured":"Aier, I., Varadwaj, P. K. & Raj, U. Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Sci. Rep. 6, 34984. https:\/\/doi.org\/10.1038\/srep34984 (2016).","journal-title":"Sci. Rep."},{"issue":"2","key":"66437_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007710","volume":"16","author":"L Stejskal","year":"2020","unstructured":"Stejskal, L. et al. Flexibility and intrinsic disorder are conserved features of hepatitis C virus E2 glycoprotein. PLoS Comput. Biol. 16(2), e1007710. https:\/\/doi.org\/10.1371\/journal.pcbi.1007710 (2020).","journal-title":"PLoS Comput. Biol."},{"issue":"4","key":"66437_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MIu Lobanov","year":"2008","unstructured":"Lobanov, MIu., Bogatyreva, N. S. & Galzitskaia, O. V. Radius of gyration is indicator of compactness of protein structure. Mol. Biol. 42(4), 701\u2013706 (2008).","journal-title":"Mol. Biol."},{"key":"66437_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105668","volume":"146","author":"P Khanal","year":"2022","unstructured":"Khanal, P. et al. Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds. Comput. Biol. Med. 146, 105668. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105668 (2022).","journal-title":"Comput. Biol. Med."},{"issue":"7","key":"66437_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1412","volume":"26","author":"Y Aikawa","year":"2008","unstructured":"Aikawa, Y. et al. Treatment of arthritis with a selective inhibitor of c-Fos\/activator protein-1. Nat. Biotechnol. 26(7), 817\u2013823. https:\/\/doi.org\/10.1038\/nbt1412 (2008).","journal-title":"Nat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66437-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66437-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66437-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:04:42Z","timestamp":1722855882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66437-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["66437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-66437-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18067"}}